Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Thomas Ray

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Preventing Chronic Disease|June 17, 2006
Progress in pediatric asthma surveillance I: the application of health care use data in Alameda County, CaliforniaEric M Roberts, Paul B English, Stephen K Van den Eeden, et al.
Vaccine|September 2, 2009
Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United StatesG Thomas Ray, Stephen I Pelton, Keith P Klugman, et al.
JAMA Dermatology|July 13, 2017
Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral LoadMaryam M Asgari, G Thomas Ray, Charles P Quesenberry, et al.
Pediatrics|February 3, 2004
Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccineLisa A Prosser, G Thomas Ray, Megan O'Brien, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 28, 2019
Depletion-of-susceptibles Bias in Analyses of Intra-season Waning of Influenza Vaccine EffectivenessG Thomas Ray, Ned Lewis, Nicola P Klein, et al.
Journal of the American Academy of Dermatology|September 18, 2017
Serious infections among a large cohort of subjects with systemically treated psoriasisAllison S Dobry, Charles P Quesenberry, G Thomas Ray, et al.
Antimicrobial Resistance and Infection Control|May 23, 2014
Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: a cost analysisCourtney A Reynolds, Jonathan A Finkelstein, G Thomas Ray, et al.
Preventive Medicine|February 8, 2018
Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health systemCynthia I Campbell, Amber L Bahorik, Paul VanVeldhuisen, et al.
Health Services Research|September 22, 2006
Cost-sharing for emergency care and unfavorable clinical events: findings from the safety and financial ramifications of ED copayments studyJohn Hsu, Mary Price, Richard Brand, et al.
Pharmacoeconomics|November 14, 2009
Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zosterTracy A Lieu, G Thomas Ray, Ismael R Ortega-Sanchez, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Preventing Chronic Disease|June 17, 2006
Progress in pediatric asthma surveillance I: the application of health care use data in Alameda County, CaliforniaEric M Roberts, Paul B English, Stephen K Van den Eeden, et al.
Vaccine|September 2, 2009
Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United StatesG Thomas Ray, Stephen I Pelton, Keith P Klugman, et al.
JAMA Dermatology|July 13, 2017
Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral LoadMaryam M Asgari, G Thomas Ray, Charles P Quesenberry, et al.
Pediatrics|February 3, 2004
Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccineLisa A Prosser, G Thomas Ray, Megan O'Brien, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 28, 2019
Depletion-of-susceptibles Bias in Analyses of Intra-season Waning of Influenza Vaccine EffectivenessG Thomas Ray, Ned Lewis, Nicola P Klein, et al.
Journal of the American Academy of Dermatology|September 18, 2017
Serious infections among a large cohort of subjects with systemically treated psoriasisAllison S Dobry, Charles P Quesenberry, G Thomas Ray, et al.
Antimicrobial Resistance and Infection Control|May 23, 2014
Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: a cost analysisCourtney A Reynolds, Jonathan A Finkelstein, G Thomas Ray, et al.
Preventive Medicine|February 8, 2018
Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health systemCynthia I Campbell, Amber L Bahorik, Paul VanVeldhuisen, et al.
Health Services Research|September 22, 2006
Cost-sharing for emergency care and unfavorable clinical events: findings from the safety and financial ramifications of ED copayments studyJohn Hsu, Mary Price, Richard Brand, et al.
Pharmacoeconomics|November 14, 2009
Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zosterTracy A Lieu, G Thomas Ray, Ismael R Ortega-Sanchez, et al.
Pageof 9